Shaare Zedek Scientific (Mada’it), our hospital’s subsidiary committed to medical research and innovation, has announced another important research collaboration with Sight Diagnostics.
Using data and analytics provided by our lab and clinical programs, the study is designed to provide early detection of blood cancers by analyzing images within the blood cells.
Dr. Renana Ofan, CEO of Shaare Zedek Scientific Ltd. (Mada’it) said that “the long-standing and fruitful collaboration between Shaare Zedek and Sight Diagnostics is an excellent example of our capacity to contribute to product development processes by providing access to data, samples, and our medical staff’s knowledge and expertise, as well as testing the products in real-world clinical settings.
Shaare Zedek’s laboratory and clinical teams are working closely with Sight’s R&D team to develop technological solutions that will enable better and faster treatments for patients in Israel and around the world.”
